451 results on '"Ostermann, Helmut"'
Search Results
52. Leitlinie : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen : ICD-10 D69.3
53. Leitlinie : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen : ICD10: D69.3
54. Sepsis in neutropenia
55. ISOLATED EPIDURAL CHLOROMA WITH TRANSLOCATION T(15; 17) SUCCESSFULLY TREATED WITH CHEMOTHERAPY AND ALL-TRANS-RETINOIC ACID
56. Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma
57. Factor XIII activity levels in patients with allogeneic haematopoietic stem cell transplantation and acute graft-versus-host disease of the gut
58. Acute Severe Spinal Cord Dysfunction in Bacterial Meningitis in Adults: MRI Findings Suggest Extensive Myelitis
59. Stellungnahme zur Nutzenbewertung gemäß § 35a SGB V eines Arzneimittels für seltene Leiden (Orphan Drug), veröffentlicht am 15. Mai 2018, Vorgangsnummer 2018-02-15-D-342, IQWiG Bericht Nr. 627
60. Leitlinie : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen
61. Gemeinsame Stellungnahme der DGHO Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie und der DGI Deutsche Gesellschaft für Infektiologie zur Nutzenbewertung des G-BA von Arzneimitteln gemäß § 35a SGB V, veröffentlicht am 2. Juli 2018, Vorgangsnummer 2018-04-01-D-353, IQWiG Bericht Nr. 641
62. Leitlinie - ICD10: D69.3 : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen
63. Patterns of Renal Recovery and Toxicity with Novel Agent-Based Induction Triplets in Newly Diagnosed Multiple Myeloma - an Analysis of Two Prospective Studies By the German DSMM Myeloma Study Group
64. Allogeneic Transplantation in Multiple Myeloma: Long-Term Follow-Up and Cytogenetic Subgroup Analysis
65. ACT-FASTER, a Prospective Cohort Study Exploring Treatment Patterns with Fulvestrant and Exemestane in Postmenopausal Patients with Advanced Hormone Receptor-Positive Breast Cancer under Real-Life Conditions in Germany
66. Inflammatory Mediators in BAL Fluid as Markers of Evolving Pneumonia in Leukocytopenic Patients*
67. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
68. Candida-Reactive T Cells for the Diagnosis of Invasive Candida Infection-A Prospective Pilot Study
69. Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study
70. Candida-Reactive T Cells for the Diagnosis of Invasive Candida Infection—A Prospective Pilot Study
71. Antifungal treatment in haematological and oncological patients: Need for quality assessment in routine care
72. Burden of Oral Mucositis: A Systematic Review and Implications for Future Research
73. How Safe Is the Administration of Long-Acting Granulocyte Colony-Stimulating Factor in Cancer Patients?
74. Immunthrombozytopenie - aktuelle Diagnostik und Therapie: Empfehlungen einer gemeinsamen Arbeitsgruppe der DGHO, ÖGHO, SGH, GPOH und DGTI
75. Immune Thrombocytopenia - Current Diagnostics and Therapy: Recommendations of a Joint Working Group of DGHO, ÖGHO, SGH, GPOH, and DGTI
76. Plerixafor in poor mobilizers with non-Hodgkin’s lymphoma: a multi-center time-motion analysis
77. Burden of oral mucositis in stem cell transplant patients—the patients’ perspective
78. Overexpression of tissue-type plasminogen activator in atherosclerotic human coronary arteries
79. Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease
80. Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease
81. Stellungnahme zur Nutzenbewertung des IQWiG gemäß § 35a SGB V, Vorgangsnummer 2015-11-15-D-192, G-BA Bericht, veröffentlicht am 15. Februar 2016, IQWiG Bericht Nr. 360, veröffentlicht am 2. Februar 2016
82. Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease
83. Prothrombin complex concentrate for vitamin K antagonist reversal in acute bleeding settings: efficacy and safety.
84. Functional characterization of Cereblon, the molecular target of immunomodulatory drugs
85. Geotrichum Capitatum-Sepsis In An Adult Patient With Acute Lymphoblastic Leukemia: A Case Report And Review Of The Literature
86. Simultaneous bilateral stereotactic body radiation therapy of two inoperable centrally located pulmonary lesions in a patient with metastatic mesenchymal chondrosarcoma
87. Blood Product Supply in Germany: The Impact of Apheresis and Pooled Platelet Concentrates
88. Treatment of invasive fungal infections in cancer patients : updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
89. Stellungnahme zur Nutzenbewertung des IQWiG gemäß § 35a SGB V, Vorgangsnummer 2013-01-15-D-051, IQWiG Bericht Nr. 159, veröffentlicht am 15. April 2013
90. Immunological Aspects of Candida and Aspergillus Systemic Fungal Infections
91. Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis
92. Pseudomonas aeruginosaNosocomial Pneumonia: Impact of Pneumonia Classification
93. Autologous Followed By Allogeneic Versus Tandem-Autologous Stem Cell Transplant in Newly Diagnosed FISH-del13q Myeloma
94. Response to Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Newly Diagnosed Multiple Myeloma Is Independent of Cytogenetic Risk and Retained after Double Stem Cell Transplant
95. Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain
96. Resource use by patients hospitalized with community-acquired pneumonia in Europe: analysis of the REACH study
97. Idiopathic hyperammonemia (IHA) after dose-dense induction chemotherapy for acute myeloid leukemia: Case report and review of the literature
98. Randomized Comparison of Safety and Pharmacokinetics of Caspofungin, Liposomal Amphotericin B, and the Combination of Both in Allogeneic Hematopoietic Stem Cell Recipients
99. Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle
100. Lenalidomide, Adriamycin and Dexamethasone (RAD) As An Induction Regimen In Newly Diagnosed Multiple Myeloma – Interim Results From a German Multicenter Phase II Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.